NEPTUNE Match Study
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Focal Segmental Glomerulosclerosis
- FSGS
- MCD
- MCD - Minimal Change Disease
- Membranous Nephropathy
- Minimal Change Disease
- Minimal Change Nephrotic Syndrome
- Nephrotic Syndrome in Children
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 85 years
- Gender
- Both males and females
Description
This is a prospective, open-label study testing the ability to effectively communicate patient-specific clinical trial matching with kidney patients and clinician investigators. The study consists of four components: Recruitment of participants from the NEPTUNE observational cohort study Generation ...
This is a prospective, open-label study testing the ability to effectively communicate patient-specific clinical trial matching with kidney patients and clinician investigators. The study consists of four components: Recruitment of participants from the NEPTUNE observational cohort study Generation of participant profile-trial match assessment using data from the NEPTUNE observational study and profiling units by the NEPTUNE Molecular Nephrology Board Establishing and testing a framework to communicate disease-trial drug mechanism matching with investigators and patients Retrospective comparison of kidney health outcomes in subjects enrolled in trials that aligned with their match vs. trial subjects with mis-aligned or unknown match alignment.
Tracking Information
- NCT #
- NCT04571658
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Investigators
- Principal Investigator: Matthias Kretzler, MD University of Michigan Study Director: Debbie GIpson, MD, MS University of Michigan